博奧森(Bioss)一直致力于新冠N、S蛋白抗原和抗體的研發(fā),不斷優(yōu)化,經(jīng)過嚴格的篩選及驗證,開發(fā)出可應用于膠體金、免疫熒光、ELISA、WB等多種方法研究的抗原及抗體。
圖2.Western Blot of McAb(Cat# bsm-41481M)to recombinant SARS-CoV-2(2019-nCoV)nucleocapsid proteins(NP)
Lane1:SARS-CoV-2 N protein(WT) at 10ng;
Lane2:SARS-CoV-2 N protein(Q9H, P67S, P80R, P151L, S183Y) at 2ng;
Lane3:SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) at 2ng;
Lane4:SARS-CoV-2 N protein(Del204 & Del215) at 2ng;
Lane5:SARS-CoV-2 N protein(R203M & D377Y) at 2ngPrimary:Anti-SARS-CoV-2 N protein at 1/1000 dilutionsecondary:IRDye800CW Goat Anti-Mouse IgG at 1/20000 dilutionPredicted band size:46kDObserved band size:46kD
新一代新冠N蛋白配對抗體,用于新冠病毒SARS-CoV-2(2019-nCoV)抗原檢測。
新冠病毒重組N蛋白測試結(jié)果:
產(chǎn)品訂購信息
Name |
Cat# |
Clone |
Application |
Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid antibody |
9D2 |
膠體金、免疫熒光、ELISA、WB |
|
7B2 |
膠體金、免疫熒光、ELISA、WB |
||
2H11 |
膠體金、免疫熒光、ELISA、WB |
||
3E7 |
膠體金、免疫熒光、ELISA、WB |
||
8C8 |
ELISA、WB |
||
9G4 |
ELISA、WB |
||
/ |
膠體金、免疫熒光、ELISA、WB |
||
1B12 |
ELISA、WB |
||
8H1 |
膠體金、免疫熒光、ELISA、WB |
||
2D5 |
ELISA、WB |
Name |
Cat# |
Region |
Mutant site |
Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid protein |
CTD |
WT |
|
Full Length |
WT |
||
NTD |
WT |
||
Full Length |
Q9H, P67S, P80R, P151L, S183Y |
||
Full Length |
D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F |
||
Full Length |
R203M, D377Y |
Name |
Cat# |
Rabbit IgG |
|
Goat Anti-Rabbit IgG Polyclonal Antibody | |
Chicken IgY | |
Goat Anti-Chicken IgY Polyclonal Antibody | |
Goat Anti-Mouse IgG Polyclonal Antibody |
參考文獻:
https://www.embopress.org/doi/10.15252/embj.2020105938
https://outbreak.info/compare-lineages?pango